Data / Form D filings / JumpCode Genomics, Inc.
JumpCode Genomics, Inc.: Form D filings
JumpCode Genomics, Inc., a biotechnology company in San Diego, CA, filed 5 Form D notices with the SEC between 2018 and 2024. The latest, on August 22, 2024, reports $3.5 million sold of a $11.5 million offering to 8 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 10055 Barnes Canyon Rd Suite 400, San Diego, CA, 92121
- Phone
- (619) 900-1701
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1698131
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 22, 2024 | New notice | $11,458,827 | $3,458,827 | $8,000,000 | 8 | Aug 15, 2024 | sec.gov |
| May 9, 2023 | New notice | $16,103,998 | $9,189,499 | $6,914,499 | 7 | Apr 27, 2023 | sec.gov |
| Dec 26, 2020 | New notice | $21,012,997 | $21,012,997 | 5 | Dec 18, 2020 | sec.gov | |
| Feb 11, 2020 | New notice | $1,500,000 | $1,500,000 | 1 | Jan 27, 2020 | sec.gov | |
| Sep 12, 2018 | New notice | $3,511,275 | $3,511,275 | 4 | Sep 4, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| David Michael Salter | Executive Officer, Director | |
| Court Michael Turner | Director | |
| Joseph Michael Lee | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Aug 19, 2024 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what JumpCode Genomics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.